Cargando…
The Development and Testing of a Chemotherapy-Induced Phlebitis Severity (CIPS) Scale for Patients Receiving Anthracycline Chemotherapy for Breast Cancer
A chemotherapy induced phlebitis severity (CIPS) scale was developed in patients receiving anthracycline chemotherapy for breast cancer. A five-point severity scoring scale for chemotherapy-induced phlebitis was tested for inter-rater reliability. Ease of use was observed through timing assessments...
Autores principales: | Harris, Valerie, Hughes, Meinir, Roberts, Rosie, Dolan, Gina, Williams, E. Mark |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7141200/ https://www.ncbi.nlm.nih.gov/pubmed/32150833 http://dx.doi.org/10.3390/jcm9030701 |
Ejemplares similares
-
Anthracycline Chemotherapy and Cardiotoxicity
por: McGowan, John V, et al.
Publicado: (2017) -
Effect of External Use of Sesame Oil in the Prevention of Chemotherapy-Induced Phlebitis
por: Nekuzad, Nilufar, et al.
Publicado: (2012) -
Advances in anthracycline chemotherapy : epirubicin /
Publicado: (1984) -
Utility of high-sensitivity cardiac troponin T in patients receiving anthracycline chemotherapy
por: Blaes, Anne H, et al.
Publicado: (2015) -
Pattern of cardiac surveillance among patients with lymphoma receiving anthracycline-based chemotherapy
por: Hung, Olivia Y, et al.
Publicado: (2015)